Advertisement

Lung

pp 1–8 | Cite as

The Effects of Aging on Exhaled Nitric Oxide (FeNO) in a North African Population

  • Sonia RouatbiEmail author
  • Ines Ghannouchi
  • Helmi Bensaad
ASTHMA
  • 19 Downloads

Abstract

Objective

To determine and explain the effect of age on exhaled nitric oxide values in North African healthy subjects aged from 5 to 83 years.

Design

Prospective cross-sectional study.

Methods

Volunteer children adults and elderly healthy subjects were included. A medical questionnaire was used to assess several subject characteristics. The levels of exhaled fraction of nitric oxide (FeNO) were measured by Medisoft HypAir FeNO method. Spirometry function test was done after the FeNO measurement. The following parameters were measured: forced vital capacity (FVC, L); 1st second forced expiratory volume (FEV1, L); FEV1/FVC ratio (absolute value); maximal mid expiratory flow (MMEF, L/s); Mid expiratory flow from 25 to 75% (MEF25%, MEF50%, and MEF75%). Statistical analyses were carried out using Statistica software with a significance set at the 0.05 level.

Results

A significant increase in FeNO is noted between groups with respective age ranges of (5, 17) and (17, 25) years with a breakpoint at 1,397,034 years. A significant decrease of FeNO is noted between groups with respective age ranges of (45, 55) and (55, 65) years with a breakpoint at 6,366,052 years. No statistical significant difference was found between females’ and males’ means FeNO data. Finally, SEL, obesity status, and hypertension contribute significantly in the variations of FeNO values.

Conclusion

The development and aging of the lung touched non-respiratory functions and so modified FeNO values in healthy North African subjects.

Keywords

Lung aging Exhaled nitric oxide North Africa Lung development 

Notes

Acknowledgements

The authors thank Ines Sfaxi, Ashraf Alquodwa, Mohamed Ali Chouchene, and all the subjects who participated in the present study.

Compliance with Ethical Standards

Conflict of interest

All authors declare that they have no conflicts of interest concerning this article.

References

  1. 1.
    Taylor DR (2006) Nitric oxide as a clinical guide for asthma management. J Allergy Clin Immunol 117(2):259–262CrossRefGoogle Scholar
  2. 2.
    Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31(1):143–178CrossRefGoogle Scholar
  3. 3.
    Olin A-C, Rosengren A, Thelle DS, Lissner L, Bake B, Torén K (2006) Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 130(5):1319–1325CrossRefGoogle Scholar
  4. 4.
    Kovesi T, Kulka R, Dales R (2008) Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest 133(1):169–175CrossRefGoogle Scholar
  5. 5.
    Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A, Tantucci C et al (2006) Reference values for exhaled nitric oxide (reveno) study. Respir Res 7:94CrossRefGoogle Scholar
  6. 6.
    Dressel H, de la Motte D, Reichert J, Ochmann U, Petru R, Angerer P et al (2008) Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med 102(7):962–969CrossRefGoogle Scholar
  7. 7.
    Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A et al (2007) Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 176(3):238–242CrossRefGoogle Scholar
  8. 8.
    Kim S-H, Kim TH, Sohn JW, Yoon HJ, Shin DH, Park SS (2010) Reference values and determinants of exhaled nitric oxide in healthy Korean adults. J Asthma Off J Assoc Care Asthma 47(5):563–567CrossRefGoogle Scholar
  9. 9.
    Rouatbi S, Alqodwa A, Ben Mdella S, Ben Saad H (2013) Fraction of exhaled nitric oxide (FeNO) norms in healthy North African children 5–16 years old. Pediatr Pulmonol 48(10):981–995CrossRefGoogle Scholar
  10. 10.
    Rouatbi S, Chouchene MA, Sfaxi I, Rejeb MB, Tabka Z, Saad HB (2014) Fraction of exhaled nitric oxide (FeNO) norms in healthy Tunisian adults. BioMed Res Int 2014:269670CrossRefGoogle Scholar
  11. 11.
    Sfaxi I, Saad HB, Rouatbi S (2015) Fraction of exhaled nitric oxide in healthy elderly Tunisian subjects. Nitric Oxide 50:88–97CrossRefGoogle Scholar
  12. 12.
    Solaligue DES, Rodríguez-Castillo JA, Ahlbrecht K, Morty RE (2017) Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 313(6):L1101–L1153CrossRefGoogle Scholar
  13. 13.
    Schittny JC (2017) Development of the lung. Cell Tissue Res 367(3):427–444CrossRefGoogle Scholar
  14. 14.
    Schmiedl A, Roolfs T, Tutdibi E, Gortner L, Monz D (2017) Influence of prenatal hypoxia and postnatal hyperoxia on morphologic lung maturation in mice. PloS ONE 12(4):e0175804CrossRefGoogle Scholar
  15. 15.
    Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270:H411–H415CrossRefGoogle Scholar
  16. 16.
    Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625–2634CrossRefGoogle Scholar
  17. 17.
    The Official Workshop Report (2004) Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med 170:319–343CrossRefGoogle Scholar
  18. 18.
    Rouatbi S, Dardouri K, Farhat Ouahchi Y, Mdella SB, Tabka Z, Guenard H (2006) Aging of the lung parenchyma. Rev Mal Respir 23(5 Pt 1):445–452CrossRefGoogle Scholar
  19. 19.
    Guénard H, Rouatbi S (2004) Physiological aspects of the decline of pulmonary function with age. Rev Mal Respir 21(5 Pt 3):8S13–8S24PubMedGoogle Scholar
  20. 20.
    Ferris BG (1978) Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118(6 Pt 2):1–120PubMedGoogle Scholar
  21. 21.
    Obesity (2000) preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1–253Google Scholar
  22. 22.
    American Thoracic Society, European Respiratory Society (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171(8):912–930CrossRefGoogle Scholar
  23. 23.
    Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968CrossRefGoogle Scholar
  24. 24.
    Tabka Z, Hassayoune H, Guenard H, Zebidi A, Commenges D, Essabah H et al (1995) Spirometric reference values in a Tunisian population. Tunis Méd 73(2):125–131PubMedGoogle Scholar
  25. 25.
    Olin A-C, Bake B, Torén K (2007) Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 131(6):1852–1856CrossRefGoogle Scholar
  26. 26.
    Habib SS, Abba AA, Al-Zoghaibi MA, Subhan MM (2009) Reference range values of fractional exhaled nitric oxide in healthy Arab adult males. Saudi Med J 30(11):1395–1400PubMedGoogle Scholar
  27. 27.
    Gelb AF, George SC, Camacho F, Fraser C, Taylor CF, Shakkottai S (2011) Increased nitric oxide concentrations in the small airway of older normal subjects. Chest 139(2):368–375CrossRefGoogle Scholar
  28. 28.
    Jo E-J, Song W-J, Kim T-W, Park H-W, Chang Y-S, Kim T-B et al (2014) Reference ranges and determinant factors for exhaled nitric oxide in a healthy korean elderly population. Allergy Asthma Immunol Res 6(6):504–510CrossRefGoogle Scholar
  29. 29.
    Matsunaga K, Hirano T, Kawayama T, Tsuburai T, Nagase H, Aizawa H, Akiyama K, Ohta K, Ichinose M (2010) Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 59(4):363–367CrossRefGoogle Scholar
  30. 30.
    Högman M, Thornadtsson A, Liv P, Hua-Huy T, Dinh-Xuan AT, Tufvesson E, Dressel H, Janson C, Koskela K, Oksa P, Sauni R, Uitti J, Moilanen E, Lehtimäki L (2017) Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects. J Breath Res 11(4):047103CrossRefGoogle Scholar
  31. 31.
    Chen E, Strunk RC, Bacharier LB, Chan M, Miller GE (2010) Socioeconomic status associated with exhaled nitric oxide responses to acute stress in children with asthma. Brain Behav Immun 24(3):444–450CrossRefGoogle Scholar
  32. 32.
    Leng B, Jin Y, Li G, Chen L, Jin N (2015) Socioeconomic status and hypertension: a meta-analysis. J Hypertens 33(2):221–229CrossRefGoogle Scholar
  33. 33.
    Ciprandi G, Schiavetti I, Fontana RB, Sorbello V, Ricciardolo FL (2014) Overweight and obesity as risk factors for impaired lung function in patients with asthma: a real-life experience. Allergy Asthma Proc 35(4):e62–e71CrossRefGoogle Scholar
  34. 34.
    Kim SH, Kim TH, Lee JS, Koo TY, Lee CB, Yoon HJ, Shin DH, Park SS, Sohn JW (2011) Adiposity, adipokines, and exhaled nitric oxide in healthy adults without asthma. J Asthma 48(2):177–182CrossRefGoogle Scholar
  35. 35.
    Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin A-C, Plummer AL, Taylor DR (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 184(5):602–615CrossRefGoogle Scholar
  36. 36.
    Travers J, Marsh S, Aldington S et al (2006) Reference values for exhaled nitric oxide (REVENO) study. Respir Res 7:94.CrossRefGoogle Scholar
  37. 37.
    Jacinto T, Malinovschi A, Janson C, Fonseca J and Alving K (2015) Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res 9(3):036005CrossRefGoogle Scholar
  38. 38.
    Bentayeb M, Billionnet C, Baiz N, Derbez M, Kirchner S, Annesi-Maesano I (2013) Higher prevalence of breathlessness in elderly exposed to indoor aldehydes and VOCs in a representative sample of French dwellings. Respir Med 107(10):1598–1607CrossRefGoogle Scholar
  39. 39.
    Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009;3(1):73–80CrossRefGoogle Scholar
  40. 40.
    Malerba M, Damiani G, Carpagnano GE, Olivini A, Radaeli A, Ragnoli B, Foschino MP, Olivieri M (2016) Values in elderly people for exhaled nitric oxide study. Rejuvenation Res 19(3):233–238CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Physiology and Functional ExplorationsFarhat HACHED HospitalSousseTunisia
  2. 2.Laboratory of Physiology, Faculty of Medicine of SousseUniversity of SousseSousseTunisia
  3. 3.Heart Failure (LR12SP09) Research LaboratoryFarhat HACHED HospitalSousseTunisia

Personalised recommendations